Am"B"valent: anti-CD20 antibodies unravel the dual role of B cells in immunopathogenesis.

Abstract:

:Accumulating evidence has designated B cells as central players in the pathogenesis of immune diseases. In the late 1990s, anti-CD20 monoclonal antibodies were developed for the treatment of B-cell non-Hodgkin lymphomas, offering the opportunity to efficiently deplete the B-cell compartment for therapeutic immunointerventions. Several studies have since established the beneficial effect of this drug on the course of a wide range of immune diseases. However, paradoxically, it has also been reported that rituximab sometimes worsens the symptoms of the very same conditions. The explanation that reconciles such apparently conflicting results has recently emerged from basic studies, which demonstrate that (1) B cells are also endowed with immune-regulatory properties and (2) the opposing contributions of B cells may overlap during the course of the disease. Caution should therefore be exercised when considering B-cell depletion because the therapeutic effect will depend on the relative contributions of the opposing B-cell activities at the time of the drug administration.

journal_name

Blood

journal_title

Blood

authors

Thaunat O,Morelon E,Defrance T

doi

10.1182/blood-2010-01-266668

subject

Has Abstract

pub_date

2010-07-29 00:00:00

pages

515-21

issue

4

eissn

0006-4971

issn

1528-0020

pii

blood-2010-01-266668

journal_volume

116

pub_type

杂志文章,评审

相关文献

BLOOD文献大全
  • Characterization of monoclonal antibodies that recognize canine CD34.

    abstract::Using a polyclonal antiserum against canine CD34, we previously found that CD34 is expressed on canine bone marrow progenitor cells in a manner analogous to that found in humans. To further characterize CD34+ cells and to facilitate preclinical canine stem cell transplant studies, monoclonal antibodies (MoAbs) were ra...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: McSweeney PA,Rouleau KA,Wallace PM,Bruno B,Andrews RG,Krizanac-Bengez L,Sandmaier BM,Storb R,Wayner E,Nash RA

    更新日期:1998-03-15 00:00:00

  • Long noncoding RNAs in biology and hematopoiesis.

    abstract::Genome and transcriptome sequencing have revealed a rich assortment of noncoding RNAs in eukaryote cells, including long noncoding RNAs (lncRNAs), which regulate gene expression independent of protein coding potential. LncRNAs modulate protein coding gene expression in many cell types by regulating multiple processes,...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2013-03-456111

    authors: Paralkar VR,Weiss MJ

    更新日期:2013-06-13 00:00:00

  • Ferritin translation by interleukin-1and interleukin-6: the role of sequences upstream of the start codons of the heavy and light subunit genes.

    abstract::Interleukin-1beta (IL-1beta) elevates H- and L-ferritin subunit synthesis in both human hepatoma cells (HepG2) and primary human umbilical vein endothelial cells. Ferritin induction is greater than the increase in total HepG2 protein synthesis in response to IL-1. IL-6 causes a moderate increase in L-subunit synthesis...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rogers JT

    更新日期:1996-03-15 00:00:00

  • Prostaglandin E(2) regulates murine hematopoietic stem/progenitor cells directly via EP4 receptor and indirectly through mesenchymal progenitor cells.

    abstract::Prostaglandin E(2) (PGE(2)) regulates hematopoietic stem/progenitor cell (HSPC) activity. However, the receptor(s) responsible for PGE(2) signaling remains unclear. Here, we identified EP4 as a receptor activated by PGE(2) to regulate HSPCs. Knockdown of Ep4 in HSPCs reduced long-term reconstitution capacity, whereas ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-06-437889

    authors: Ikushima YM,Arai F,Hosokawa K,Toyama H,Takubo K,Furuyashiki T,Narumiya S,Suda T

    更新日期:2013-03-14 00:00:00

  • Polyphosphate colocalizes with factor XII on platelet-bound fibrin and augments its plasminogen activator activity.

    abstract::Activated factor XII (FXIIa) has plasminogen activator capacity but its relative contribution to fibrinolysis is considered marginal compared with urokinase and tissue plasminogen activator. Polyphosphate (polyP) is released from activated platelets and mediates FXII activation. Here, we investigate the contribution o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-10-673285

    authors: Mitchell JL,Lionikiene AS,Georgiev G,Klemmer A,Brain C,Kim PY,Mutch NJ

    更新日期:2016-12-15 00:00:00

  • Stratification of pediatric ALL by in vitro cellular responses to DNA double-strand breaks provides insight into the molecular mechanisms underlying clinical response.

    abstract::The molecular basis of different outcomes in pediatric acute lymphoblastic leukemia (ALL) remains poorly understood. We addressed the clinical significance and mechanisms behind in vitro cellular responses to ionizing radiation (IR)-induced DNA double-strand breaks in 74 pediatric patients with ALL. We found an apopto...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-03-142950

    authors: Marston E,Weston V,Jesson J,Maina E,McConville C,Agathanggelou A,Skowronska A,Mapp K,Sameith K,Powell JE,Lawson S,Kearns P,Falciani F,Taylor M,Stankovic T

    更新日期:2009-01-01 00:00:00

  • Fbw7γ-mediated degradation of KLF13 prevents RANTES expression in resting human but not murine T lymphocytes.

    abstract::RANTES (CCL5) is a chemokine implicated in many human diseases. We previously showed that the transcription factor Kruppel-like factor 13 (KLF13) controls the late (3-5 days after activation) expression of RANTES in T lymphocytes and that KLF13 itself is translationally regulated through the 5'-untranslated region of ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2012-03-415968

    authors: Kim DS,Zhang W,Millman SE,Hwang BJ,Kwon SJ,Clayberger C,Pagano M,Krensky AM

    更新日期:2012-08-23 00:00:00

  • Proteasome activity restricts lentiviral gene transfer into hematopoietic stem cells and is down-regulated by cytokines that enhance transduction.

    abstract::The therapeutic potential of hematopoietic stem cell (HSC) gene therapy can be fully exploited only by reaching efficient gene transfer into HSCs without compromising their biologic properties. Although HSCs can be transduced by HIV-derived lentiviral vectors (LVs) in short ex vivo culture, they display low permissivi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2005-10-4047

    authors: Santoni de Sio FR,Cascio P,Zingale A,Gasparini M,Naldini L

    更新日期:2006-06-01 00:00:00

  • Pivotal role of mast cells in pruritogenesis in patients with myeloproliferative disorders.

    abstract::Pruritus is a common symptom in patients with Philadelphia chromosome-negative myeloproliferative disorders (MPDs). The pathophysiology of MPD-associated pruritus is unclear. We have demonstrated that MPD mast cells (MCs) are involved by the malignant process. In the present study, we explored the hypothesis that MCs ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-179416

    authors: Ishii T,Wang J,Zhang W,Mascarenhas J,Hoffman R,Dai Y,Wisch N,Xu M

    更新日期:2009-06-04 00:00:00

  • Native human blood dendritic cells as potent effectors in antibody-dependent cellular cytotoxicity.

    abstract::Functional studies on native human dendritic cells (DCs) are hampered by technical difficulties in preparing fresh DCs. Recently, with the help of the monoclonal antibody M-DC8, we succeeded in isolating a major subpopulation of human blood DCs by a one-step immunomagnetic separation procedure. These cells strongly ex...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Schmitz M,Zhao S,Schäkel K,Bornhäuser M,Ockert D,Rieber EP

    更新日期:2002-08-15 00:00:00

  • Sequestration of p27Kip1 protein by cyclin D1 in typical and blastic variants of mantle cell lymphoma (MCL): implications for pathogenesis.

    abstract::p27 is a cyclin-dependent kinase inhibitor that plays a critical role in regulating G(1)/S progression, and whose activity is, in part, regulated through interactions with D-type cyclins. Mantle cell lymphoma (MCL) is characterized by the t(11;14) translocation resulting in deregulated cyclin D1. We previously showed ...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2002-01-0263

    authors: Quintanilla-Martinez L,Davies-Hill T,Fend F,Calzada-Wack J,Sorbara L,Campo E,Jaffe ES,Raffeld M

    更新日期:2003-04-15 00:00:00

  • Platelet membrane glycoprotein IIb heavy chain forms a complex with glycoprotein IIIa that binds Arg-Gly-Asp peptides.

    abstract::Platelet membrane GPIIb is comprised of a disulfide-linked heavy chain (GPIIb(H)) and light chain (GPIIb(L)). We have examined the role of the two chains of GPIIb in the maintenance of the GPIIb-IIIa heterodimer and Arg-Gly-Asp (RGD) peptide-binding function. Lysates of surface radioiodinated platelets were treated wi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Lam SC,Plow EF,Ginsberg MH

    更新日期:1989-05-01 00:00:00

  • Distinctive localization of antigen-presenting cells in human lymph nodes.

    abstract::Professional antigen-presenting cells (APCs) are sentinel cells of the immune system that present antigen to T lymphocytes and mediate an appropriate immune response. It is therefore surprising that knowledge of the professional APCs in human lymph nodes is limited. Using 3-color immunohistochemistry, we have identifi...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-06-165266

    authors: Angel CE,Chen CJ,Horlacher OC,Winkler S,John T,Browning J,MacGregor D,Cebon J,Dunbar PR

    更新日期:2009-02-05 00:00:00

  • CD40 activation does not protect chronic lymphocytic leukemia B cells from apoptosis induced by cytotoxic T lymphocytes.

    abstract::Cytotoxic T lymphocytes (CTLs) can kill target cells by the granule/exocytosis pathway or the Fas-mediated apoptosis pathway. The sensitivity of chronic lymphocytic leukemia (CLL) B cells to CTL-mediated apoptosis before and after CD40 activation was examined. Resting or CD40-activated CLL cells were found to be equal...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Chu P,Wierda WG,Kipps TJ

    更新日期:2000-06-15 00:00:00

  • Targeted mutagenesis of zebrafish antithrombin III triggers disseminated intravascular coagulation and thrombosis, revealing insight into function.

    abstract::Pathologic blood clotting is a leading cause of morbidity and mortality in the developed world, underlying deep vein thrombosis, myocardial infarction, and stroke. Genetic predisposition to thrombosis is still poorly understood, and we hypothesize that there are many additional risk alleles and modifying factors remai...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2014-03-561027

    authors: Liu Y,Kretz CA,Maeder ML,Richter CE,Tsao P,Vo AH,Huarng MC,Rode T,Hu Z,Mehra R,Olson ST,Joung JK,Shavit JA

    更新日期:2014-07-03 00:00:00

  • Inhibition of IL-32 activation by α-1 antitrypsin suppresses alloreactivity and increases survival in an allogeneic murine marrow transplantation model.

    abstract::Interleukin (IL)-32 was originally identified in natural killer cells and IL-2-activated human T lymphocytes. As T cells are activated in allogeneic transplantation, we determined the role of IL-32 in human mixed lymphocyte cultures (MLCs) and GVHD. In allogeneic MLCs, IL-32 increased two-fold in responding T cells, a...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-07-365247

    authors: Marcondes AM,Li X,Tabellini L,Bartenstein M,Kabacka J,Sale GE,Hansen JA,Dinarello CA,Deeg HJ

    更新日期:2011-11-03 00:00:00

  • The vascular endothelial-cadherin promoter directs endothelial-specific expression in transgenic mice.

    abstract::Vascular endothelial-cadherin (VE-cadherin) is a calcium-dependent adhesive molecule, exclusively and constitutively expressed in endothelial cells. Analysis of the VE-cadherin promoter fused to a reporter gene in bovine aortic endothelial cells showed three major functional regions. The proximal region alone (-139, +...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Gory S,Vernet M,Laurent M,Dejana E,Dalmon J,Huber P

    更新日期:1999-01-01 00:00:00

  • Regulatory T cells differentially modulate the maturation and apoptosis of human CD8+ T-cell subsets.

    abstract::The balanced manifestation of effector functions and the generation of long-living memory cells is a hallmark of efficient CD8(+) T-cell response. Accumulating data pinpoint CD4(+) CD25(high) regulatory T (Treg) cells as a key factor for the inefficiency of CD8(+) T-cell responses in viral persistence. Little is known...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-04-151407

    authors: Nikolova M,Lelievre JD,Carriere M,Bensussan A,Lévy Y

    更新日期:2009-05-07 00:00:00

  • Double CEBPA mutations, but not single CEBPA mutations, define a subgroup of acute myeloid leukemia with a distinctive gene expression profile that is uniquely associated with a favorable outcome.

    abstract::Mutations in CCAAT/enhancer binding protein alpha (CEBPA) are seen in 5% to 14% of acute myeloid leukemia (AML) and have been associated with a favorable clinical outcome. Most AMLs with CEBPA mutations simultaneously carry 2 mutations (CEBPA(double-mut)), usually biallelic, whereas single heterozygous mutations (CEBP...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2008-09-179895

    authors: Wouters BJ,Löwenberg B,Erpelinck-Verschueren CA,van Putten WL,Valk PJ,Delwel R

    更新日期:2009-03-26 00:00:00

  • Identification of risk groups for development of central nervous system leukemia in adults with acute lymphocytic leukemia.

    abstract::The risk of development of CNS leukemia was investigated in 153 adults with acute lymphocytic leukemia (ALL) who received systemic combination chemotherapy without CNS prophylaxis. Overall, 31 patients (20%) developed CNS leukemia after a median of 6 months of therapy; the estimated 1-year incidence of CNS leukemia wa...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Kantarjian HM,Walters RS,Smith TL,Keating MJ,Barlogie B,McCredie KB,Freireich EJ

    更新日期:1988-11-01 00:00:00

  • Regulation of type I plasminogen activator inhibitor by fibrin degradation products in rat lung fibroblasts.

    abstract::Persistent fibrin deposition in tissues characterizes the early pathology of many types of injury. In an animal model of bleomycin-induced lung fibrosis, increased expression of type 1 plasminogen activator inhibitor (PAI-1) is associated with accumulation of fibrin in fibroproliferative lesions. Plasmin proteolysis o...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Hagood JS,Olman MA,Godoy JA,Rivera KE,Fuller GM

    更新日期:1996-05-01 00:00:00

  • Identification of a restriction fragment length polymorphism involving the oncogene ETS-1 on chromosome 11q23.

    abstract::Twenty four samples of DNA from 23 unrelated individuals were analyzed for the presence of a novel restriction fragment length polymorphism (RFLP) involving the proto-oncogene ETS-1 at an Xba I site. Four samples from unrelated individuals lacked an Xba I site, giving rise to a longer restriction fragment detectable b...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Savage PD,Hanson CA,Kersey JH

    更新日期:1987-07-01 00:00:00

  • Natural killer cell receptors: new biology and insights into the graft-versus-leukemia effect.

    abstract::Natural killer (NK) cells have held great promise for the immunotherapy of cancer for more than 3 decades. However, to date only modest clinical success has been achieved manipulating the NK cell compartment in patients with malignant disease. Progress in the field of NK cell receptors has revolutionized our concept o...

    journal_title:Blood

    pub_type: 杂志文章,评审

    doi:10.1182/blood-2002-02-0350

    authors: Farag SS,Fehniger TA,Ruggeri L,Velardi A,Caligiuri MA

    更新日期:2002-09-15 00:00:00

  • Characterization of the retinoid binding properties of the major fusion products present in acute promyelocytic leukemia cells.

    abstract::The bcr1- and bcr3- promyelocytic leukemia/retinoic acid receptor alpha (PML/RAR alpha) are the two major fusion proteins expressed in acute promyelocytic leukemia (APL) patients. These proteins, which are present in different lengths of PML (amino acids 1-552 and 1-394, respectively), contain most of the functional d...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Benedetti L,Levin AA,Scicchitano BM,Grignani F,Allenby G,Diverio D,Lo Coco F,Avvisati G,Ruthardt M,Adamo S,Pelicci PG,Nervi C

    更新日期:1997-08-01 00:00:00

  • TNFα facilitates clonal expansion of JAK2V617F positive cells in myeloproliferative neoplasms.

    abstract::Proinflammatory cytokines such as TNFα are elevated in patients with myeloproliferative neoplasms (MPN), but their contribution to disease pathogenesis is unknown. Here we reveal a central role for TNFα in promoting clonal dominance of JAK2(V617F) expressing cells in MPN. We show that JAK2(V617F) kinase regulates TNFα...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2011-04-348144

    authors: Fleischman AG,Aichberger KJ,Luty SB,Bumm TG,Petersen CL,Doratotaj S,Vasudevan KB,LaTocha DH,Yang F,Press RD,Loriaux MM,Pahl HL,Silver RT,Agarwal A,O'Hare T,Druker BJ,Bagby GC,Deininger MW

    更新日期:2011-12-08 00:00:00

  • Phosphoinositide 3-kinase inhibition restores neutrophil accuracy in the elderly: toward targeted treatments for immunosenescence.

    abstract::Immunosenescence is the functional deterioration of the immune system during natural aging. Despite increased susceptibility to bacterial infections in older adults, age-associated changes to neutrophil responses are only partially understood, and neutrophil migration has not been characterized in detail. Here we desc...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2013-08-519520

    authors: Sapey E,Greenwood H,Walton G,Mann E,Love A,Aaronson N,Insall RH,Stockley RA,Lord JM

    更新日期:2014-01-09 00:00:00

  • A high-throughput sequencing test for diagnosing inherited bleeding, thrombotic, and platelet disorders.

    abstract::Inherited bleeding, thrombotic, and platelet disorders (BPDs) are diseases that affect ∼300 individuals per million births. With the exception of hemophilia and von Willebrand disease patients, a molecular analysis for patients with a BPD is often unavailable. Many specialized tests are usually required to reach a put...

    journal_title:Blood

    pub_type: 杂志文章

    doi:10.1182/blood-2015-12-688267

    authors: Simeoni I,Stephens JC,Hu F,Deevi SV,Megy K,Bariana TK,Lentaigne C,Schulman S,Sivapalaratnam S,Vries MJ,Westbury SK,Greene D,Papadia S,Alessi MC,Attwood AP,Ballmaier M,Baynam G,Bermejo E,Bertoli M,Bray PF,Bury L,

    更新日期:2016-06-09 00:00:00

  • Cell cycle analysis and synchronization of pluripotent hematopoietic progenitor stem cells.

    abstract::Hematopoietic stem cells purified from mouse bone marrow are quiescent with less than 2% of Lin- Hoechst(low)/Rhodamine(low) (Lin- Ho(low)/Rho(low)) and 10% to 15% of Lin-/Sca+ cells in S phase. These cells enter proliferative cycle and progress through G1 and into S phase in the presence of cytokines and 5% heat-inac...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Reddy GP,Tiarks CY,Pang L,Wuu J,Hsieh CC,Quesenberry PJ

    更新日期:1997-09-15 00:00:00

  • Clinical efficacy of zanolimumab (HuMax-CD4): two phase 2 studies in refractory cutaneous T-cell lymphoma.

    abstract::The efficacy and safety of zanolimumab in patients with refractory cutaneous T-cell lymphoma (CTCL) have been assessed in two phase 2, multicenter, prospective, open-label, uncontrolled clinical studies. Patients with treatment refractory CD4(+) CTCL (mycosis fungoides [MF], n = 38; Sézary syndrome [SS], n = 9) receiv...

    journal_title:Blood

    pub_type: 杂志文章,多中心研究

    doi:10.1182/blood-2006-12-062877

    authors: Kim YH,Duvic M,Obitz E,Gniadecki R,Iversen L,Osterborg A,Whittaker S,Illidge TM,Schwarz T,Kaufmann R,Cooper K,Knudsen KM,Lisby S,Baadsgaard O,Knox SJ

    更新日期:2007-06-01 00:00:00

  • Heterogeneity in therapeutic response of genetically altered myeloma cell lines to interleukin 6, dexamethasone, doxorubicin, and melphalan.

    abstract::Because there is no known genetic abnormality common to all patients with myeloma, it is important to understand how genetic heterogeneity may lead to differences in signal transduction, cell cycle, and response to therapy. Model cell lines have been used to study the effect that mutations in p53 and ras can have on g...

    journal_title:Blood

    pub_type: 杂志文章

    doi:

    authors: Rowley M,Liu P,Van Ness B

    更新日期:2000-11-01 00:00:00